BOT 4.05% 38.5¢ botanix pharmaceuticals ltd

BOT - Anything but charting, page-2466

  1. 2,468 Posts.
    lightbulb Created with Sketch. 3450
    Management have lost my respect when they stuffed the BTX1503 US trials. Ultimately this is what hurt Botanix and to this day the market has punished the hell out of it.

    Market have no respect for BOT and they showed that when the best ever company announcement was made related to BTX1801 backed up by a $6M cash injection. Market does not forget and almost never forgive.

    The only thing that will bring back the market and little league traders is a commercial deal or maybe a complete overhaul of management.

    BTX1503 was an absolute disaster even though we had great results in AU, BTX1204 was a total waste of time and effort and BTX1801 was amazing and the market did not care.

    So what is management doing now to restore market respect and confidence????? I assume nothing.

    Looking forward to seeing the BTX1702 enrolment completion WoW how excitingly boring.

    See you all in 5 years.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.